NCT02107313View on ClinicalTrials.gov

Phase 1 Study to Determine the Effects of Food on the Pharmacokinetic Profile of PBT2

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

June 30, 2014

Study Completion Date

July 31, 2014

Conditions
Healthy Volunteers
Interventions
DRUG

Fed Cohort PBT2

PBT2 250 mg is administered orally following a period of fasting for 10 hours and a high fat breakfast.

DRUG

Fasted Cohort PBT2

PBT2 250 mg is administered orally after a period of fasting of 10 hours and without food

Trial Locations (1)

3004

Centre for Clinical Studies - Nucleus Network, Melbourne

Sponsors
All Listed Sponsors
lead

Prana Biotechnology Limited

INDUSTRY